Quick Answer
Phio Pharmaceuticals Corp. reported Stockholders Equity of $20.15 million for the year ending 2025.
- Phio Pharmaceuticals Corp. showed an increase of +326.6% in Stockholders Equity from 2024 to 2025.
- This data is from Phio Pharmaceuticals Corp.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2006 to 2025 (20 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2014: $2.75 million | Q1 2015: $2.53 million | Q2 2015: $13.13 million | Q3 2015: $11.03 million | Q1 2016: $6.95 million | Q2 2016: $4.97 million | Q3 2016: $3.04 million | Q1 2017: $8.25 million | Q2 2017: $5.94 million | Q3 2017: $3.43 million | Q1 2018: $567.0 thousand | Q2 2018: $3.27 million | Q3 2018: $1.75 million | Q1 2019: $11.66 million | Q2 2019: $9.71 million | Q3 2019: $7.61 million | Q1 2020: $11.99 million | Q2 2020: $17.73 million | Q3 2020: $15.45 million | Q1 2021: $31.40 million | Q2 2021: $28.85 million | Q3 2021: $25.25 million | Q1 2022: $19.45 million | Q2 2022: $17.00 million | Q3 2022: $13.53 million | Q1 2023: $7.31 million | Q2 2023: $9.90 million | Q3 2023: $7.21 million | Q1 2024: $5.60 million | Q2 2024: $3.77 million | Q3 2024: $4.95 million | Q1 2025: $12.17 million | Q2 2025: $10.10 million | Q3 2025: $9.84 million.
- Over the full 20 years of available data (2006 to 2025), Phio Pharmaceuticals Corp.'s Stockholders Equity has grown by 7,617.5%.
- Historical annual values: Fiscal year 2025: $20.15 million | Fiscal year 2024: $4.72 million | Fiscal year 2023: $7.73 million | Fiscal year 2022: $10.84 million | Fiscal year 2021: $21.93 million | Fiscal year 2020: $13.02 million | Fiscal year 2019: $5.75 million | Fiscal year 2018: $13.58 million | Fiscal year 2017: $1.83 million | Fiscal year 2016: $10.86 million | Fiscal year 2015: $8.89 million | Fiscal year 2014: $2.75 million | Fiscal year 2013: $4.94 million | Fiscal year 2012: -$5.84 million | Fiscal year 2011: -$587.0 thousand | Fiscal year 2010: $2.43 million | Fiscal year 2009: $741.0 thousand | Fiscal year 2008: $8.97 million | Fiscal year 2007: $10.82 million | Fiscal year 2006: -$268.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: